☆ 4.6 Editorial Material

Editorial Comment on: FDG-PET/CT for the Preoperative Lymph Node Staging of Invasive Bladder Cancer

EUROPEAN UROLOGY (2010)

期刊

EUROPEAN UROLOGY

卷 57, 期 4, 页码 647-647

出版社

ELSEVIER SCIENCE BV

DOI: 10.1016/j.eururo.2009.05.021

关键词

-

类别

Urology & Nephrology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Oncology

18F-FDG PET/CT Radiomics for Preoperative Prediction of Lymph Node Metastases and Nodal Staging in Gastric Cancer

Qiufang Liu, Jiaru Li, Bowen Xin, Yuyun Sun, Dagan Feng, Michael J. J. Fulham, Xiuying Wang, Shaoli Song

Summary: This study developed and validated two machine learning models based on preoperative F-18-FDG PET/CT images that have predictive value for LNMs and the N stage in gastric cancer. These predictive models show promise as a potentially useful adjunct to current staging approaches for patients with gastric cancer.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Diagnostic performance of preoperative [18F]FDG-PET/CT for lymph node staging in vulvar cancer: a large single-centre study

Vittoria Rufini, Giorgia Garganese, Francesco P. Ieria, Tina Pasciuto, Simona M. Fragomeni, Benedetta Gui, Anita Florit, Frediano Inzani, Gian Franco Zannoni, Giovanni Scambia, Alessandro Giordano, Angela Collarino

Summary: In this retrospective study of vulvar cancer patients, [F-18]FDG-PET/CT demonstrated good sensitivity and negative predictive value in predicting the status of groin and pelvic lymph nodes, highlighting the reliability of qualitative analysis over semi-quantitative methods.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Diagnostic Performance of F-18-FDG PET/CT for Lymph Node Staging in Penile Cancer

Sang Woo Lee, Seong-Jang Kim

Summary: The systematic review and meta-analysis showed that F-18-FDG PET/CT has good diagnostic performance in detecting lymph node metastasis in penile cancer patients, with similar accuracy in detecting inguinal and pelvic lymph node metastasis.

CLINICAL NUCLEAR MEDICINE (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Preoperative pelvic MRI and 2-[18F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer-time to revisit current imaging guidelines?

Kristine E. Fasmer, Ankush Gulati, Julie A. Dybvik, Kari S. Wagner-Larsen, Njal Lura, Oyvind Salvesen, David Forsse, Jone Trovik, Johanna M. A. Pijnenborg, Camilla Krakstad, Ingfrid S. Haldorsen

Summary: This study evaluated the diagnostic performance of four different preoperative imaging workups for predicting lymph node metastases in endometrial cancer. The results showed that selective use of [F-18]FDG-PET/CT in patients with high-risk MRI findings detected lymph node metastases better than MRI alone.

EUROPEAN RADIOLOGY (2023)

添加到收藏夹

Article Health Care Sciences & Services

Optimization of Preoperative Lymph Node Staging in Patients with Muscle-Invasive Bladder Cancer Using Radiomics on Computed Tomography

Martijn P. A. Starmans, Li Shen Ho, Fokko Smits, Nick Beije, Inge de Kruijff, Joep J. de Jong, Diederik M. Somford, Egbert R. Boeve, Ed Te Slaa, Evelyne C. C. Cauberg, Sjoerd Klaver, Antoine G. van der Heijden, Carl J. Wijburg, Addy C. M. van de Luijtgaarden, Harm H. E. van Melick, Ella Cauffman, Peter de Vries, Rens Jacobs, Wiro J. Niessen, Jacob J. Visser, Stefan Klein, Joost L. Boormans, Astrid A. M. van der Veldt

Summary: The study aimed to evaluate the ability of CT-based radiomics to differentiate between pN+ and pN0 disease in patients with clinical stage cT2-T4aN0-N1M0 MIBC. The results showed that radiomics features did not significantly differentiate between pN+ and pN0 disease, and the radiomics models performed no better than random guessing.

JOURNAL OF PERSONALIZED MEDICINE (2022)

添加到收藏夹

Article Oncology

F-18-FDG PET/CT-based radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer

Xiu-qing Xue, Wen-Ji Yu, Xun Shi, Xiao-Liang Shao, Yue-Tao Wang

Summary: This study developed a radiomics nomogram using preoperative F-18-FDG PET/CT primary lesions and clinical risk factors to predict lymph node metastasis in gastric cancer patients. The nomogram showed good performance in predicting lymph node metastasis and can contribute to risk stratification in gastric cancer patients.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Diagnostic values of F-18 FDG PET or PET/CT, CT, and US for Preoperative Lymph Node Staging in Thyroid Cancer: A Network Meta-Analysis

Keunyoung Kim, Sung-Ryul Shim, Sang-Woo Lee, Seong-Jang Kim

Summary: This study compared the diagnostic performance of F-18 FDG PET/PET CT, CT, and US for preoperative LN staging in thyroid cancer patients using a network meta-analysis. Ultrasound showed the highest SUCRA values for PPV, NPV, and accuracy in detecting LN metastasis, while F-18 FDG PET or PET/CT and US had the highest SUCRA values for PPV, sensitivity, specificity, and sensitivity for different LN regions.

BRITISH JOURNAL OF RADIOLOGY (2021)

添加到收藏夹

Article Oncology

The role of 18F-FDG PET/CT scan compared to CT-scan alone for lymph node staging before radical cystectomy in patients with bladder cancer

Mohamad Moussa, Mohamad Abou Chakra, Wajih Saad, Athanasios Dellis, Athanasios Papatsoris

Summary: PET-CT is more accurate and sensitive than CT scan alone for preoperative LN staging in patients with bladder cancer, providing better diagnostic value for LN metastasis.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

添加到收藏夹

Review Oncology

The increasing indications of FDG-PET/CT in the staging and management of Invasive Bladder Cancer

Nicolas Pavlos Omorphos, Aruni Ghose, John D. B. Hayes, Abhinav Kandala, Prokar Dasgupta, Anand Sharma, Nikhil Vasdev

Summary: This paper reviews the evolving indications of FDG-PET/CT imaging in pre-clinical and post-treatment staging of bladder cancer, with a focus on its ability to evaluate response to NAC. The study concluded that FDG-PET/CT allows for improved nodal staging and metastatic disease detection compared to traditional imaging techniques.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)

添加到收藏夹

Editorial Material Medicine, General & Internal

A Rare Axillary Lymph Node Metastasis on 18F-FDG PET/CT for Staging in a Patient with Common Bile Duct Cancer

Yeongjoo Lee, Hye Sung Won, Kyung Jin Seo, Sae Jung Na

Summary: This article presents an interesting case of distant lymph node metastasis in a patient with common bile duct cancer, which was detected using F-18-FDG PET scanning.

DIAGNOSTICS (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection

Ja Kyung Yoon, Mi-Suk Park, Seung-Seob Kim, Kyunghwa Han, Hee Seung Lee, Seungmin Bang, Ho Kyoung Hwang, Sang Hyun Hwang, Mijin Yun, Myeong-Jin Kim

Summary: The objective of this study was to evaluate the role of regional lymph node (LN) metastasis detected on preoperative CT and/or FDG-PET scans in the prediction of early tumor recurrence after curative surgical resection of pancreatic ductal adenocarcinoma (PDAC). The study found that preoperative CA19-9 levels, preoperative locally advanced status, and regional LN metastasis were significant risk factors for early recurrence. The LNOR criteria provided higher sensitivity and negative predictive value compared to the LNAND criteria.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

A machine-learning-based combination of criteria to detect bladder cancer lymph node metastasis on [18F]FDG PET/CT: a pathology-controlled study

Antoine Girard, Laurent Dercle, Helena Vila-Reyes, Lawrence H. Schwartz, Astrid Girma, Marc Bertaux, Camelia Radulescu, Thierry Lebret, Olivier Delcroix, Mathieu Rouanne

Summary: By using machine learning, we developed a combination of criteria that accurately identifies pelvic lymph node involvement in bladder cancer patients. The diagnostic performance of this combination is comparable to that of a consensus of experts on [F-18]FDG PET/CT scans.

EUROPEAN RADIOLOGY (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Is Delayed Image of F-18-FDG PET/CT Necessary for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer Patients?

Sang Woo Lee, Seong-Jang Kim

Summary: This study evaluated the diagnostic accuracies of dual-time-point F-18-FDG PET/CT for detecting metastatic mediastinal lymph nodes in NSCLC patients. Results showed that dual-time-point F-18-FDG PET/CT exhibited good diagnostic performances for detecting metastatic mediastinal LNs, with retention index or %Delta SUVmax being superior to early or delayed images for detection of mediastinal LN metastasis.

CLINICAL NUCLEAR MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

FDG PET/CT and Endoscopic Ultrasound for Preoperative T-Staging of Esophageal Squamous Cell Carcinoma

Yung-Cheng Huang, Nan-Tsing Chiu, Hung- Lu, Yi-Chun Chiu, Chien-Chin Hsu, Yu-Ming Wang, Shau-Hsuan Li

Summary: This study compared the diagnostic performances of endoscopic ultrasound (EUS) and FDG PET/CT in predicting the T-staging of esophageal squamous cell carcinoma (ESCC) and found that FDG PET/CT had higher overall accuracy than EUS. The combination of both imaging modalities achieved higher accuracies in differentiating between early and locally advanced disease and determining residual viable tumor. FDG PET/CT was superior to EUS in predicting the (y)pT-stage of ESCC.

DIAGNOSTICS (2023)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Pelvic lymph-node staging with18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer-the SALT trial

B. H. E. Jansen, Y. J. L. Bodar, G. J. C. Zwezerijnen, D. Meijer, J. P. van der Voorn, J. A. Nieuwenhuijzen, M. Wondergem, T. A. Roeleveld, R. Boellaard, O. S. Hoekstra, R. J. A. van Moorselaar, D. E. Oprea-Lager, A. N. Vis

Summary: The study found that F-18-DCFPyL PET/CT has high specificity but limited sensitivity for detecting pelvic lymph-node metastases in primary prostate cancer patients. Therefore, current PSMA PET/CT imaging cannot fully replace diagnostic ePLND. Further research is needed to determine the exact role of PSMA PET/CT imaging in the primary staging of prostate cancer.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

添加到收藏夹

Article Cell Biology

The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancer

Tino Vollmer, Stephan Schlickeiser, Leila Amini, Sarah Schulenberg, Desiree J. Wendering, Viqar Banday, Anke Jurisch, Rebecca Noster, Desiree Kunkel, Nicola R. Brindle, Ioannis Savidis, Levent Akyuz, Jochen Hecht, Ulrik Stervbo, Toralf Roch, Nina Babel, Petra Reinke, Ola Winqvist, Amir Sherif, Hans-Dieter Volk, Michael Schmueck-Henneresse

Summary: The CXCR3-CXCL11 chemokine system plays a crucial role in predicting chemotherapy responsiveness in MIBC by stimulating CD8(+) T cells. The presence of CXCR3alt and CXCL11 can differentiate responder and nonresponder patients before treatment, and may provide immunotherapeutic options for activating intratumoral stem-like T cells in solid tumors.

SCIENCE TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Cumulative incidence of midline incisional hernia and its surgical treatment after radical cystectomy and urinary diversion for bladder cancer: A nation-wide population-based study

Fredrik Liedberg, Oskar Hagberg, Firas Aljabery, Truls Gardmark, Staffan Jahnson, Tomas Jerlstrom, Agneta Montgomery, Amir Sherif, Viveka Strock, Christel Haggstrom, Lars Holmberg

Summary: The cumulative incidence of midline incisional hernia (MIH) three years after cystectomy was 8%, with an increased risk associated with postoperative wound dehiscence. Surgical treatment for MIH was needed in 4% of patients.

PLOS ONE (2021)

添加到收藏夹

Article Oncology

Proteomic Profiling of Tissue Exosomes Indicates Continuous Release of Malignant Exosomes in Urinary Bladder Cancer Patients, Even with Pathologically Undetectable Tumour

Maria Eldh, Michael Mints, Stefanie Hiltbrunner, Sam Ladjevardi, Farhood Alamdari, Markus Johansson, Tomasz Jakubczyk, Rosanne E. Veerman, Ola Winqvist, Amir Sherif, Susanne Gabrielsson

Summary: The study investigated the release of exosomes from urinary bladder tissue post-TUR-B in UBC patients to find cancer-promoting exosomes originating from both tumour-proximal and tumour-distant sites, highlighting the need for early radical cystectomy. This suggests that the entire bladder tissue may release exosomes contributing to metastasis despite the absence of detectable tumour, supporting the role of exosomes as potential biomarkers and mediators of metastatic spread. Additionally, the enrichment of cancer-related pathways in tissue-derived exosomes from both sites strengthens the hypothesis and emphasizes the necessity for early removal of the bladder in UBC patients.

CANCERS (2021)

添加到收藏夹

Article Urology & Nephrology

Control computerized tomography in neoadjuvant chemotherapy for muscle invasive urinary bladder cancer, has no value for treatment decisions and low correlation with nodal status

S. Tenninge, H. Mogos, E. Eriksson, H. Netterling, S. Pelander, M. Johansson, F. Alamdari, Y. Huge, F. Aljabery, J. Svensson, J. Styrke, A. Sherif

Summary: Background Control computerized tomography (cCT) is routinely used in many cystectomy centres before the final treatment cycle in patients with muscle-invasive urinary bladder cancer (MIBC) undergoing neoadjuvant chemotherapy (NAC). This study aimed to evaluate the frequency of changed treatment strategies following cCT and investigate discrepancies between cCT results and final nodal staging. The results showed a low percentage of treatment strategy changes after cCT and that cCT cannot accurately predict pN-status in MIBC patients undergoing NAC.

SCANDINAVIAN JOURNAL OF UROLOGY (2021)

添加到收藏夹

Article Urology & Nephrology

Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer

Beth Russell, Fredrik Liedberg, Oskar Hagberg, Anders Ullen, Karin Soderkvist, Viveka Strock, Firas Aljabery, Truls Gardmark, Tomas Jerlstrom, Amir Sherif, Lars Holmberg, Richard T. Bryan, Deborah Enting, Mieke Van Hemelrijck

Summary: Patients diagnosed with non-muscle-invasive bladder cancer at age <50 have a decreased risk of bladder cancer-specific death compared to those aged 50-70, with no significant difference in lower urinary tract infection diagnoses between age groups. These findings suggest potential age-related differences in diagnostic procedures, clinical decision-making, and tumor biology.

SCANDINAVIAN JOURNAL OF UROLOGY (2022)

添加到收藏夹

Article Urology & Nephrology

Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999: a population-based study

Johannes Bobjer, Oskar Hagberg, Firas Aljabery, Truls Gardmark, Staffan Jahnson, Tomas Jerlstrom, Amir Sherif, Athanasious Simoulis, Viveka Strock, Christel Haggstrom, Lars Holmberg, Fredrik Liedberg

Summary: This study found that compared to PUNLMP, TaG1 bladder cancer has a higher risk of recurrence, while progression events were too few to compare.

SCANDINAVIAN JOURNAL OF UROLOGY (2022)

添加到收藏夹

Editorial Material Urology & Nephrology

Do not throw out the baby with the bath water

Suleiman Abuhasanein, Staffan Jahnson, Firas Aljabery, Truls Gardmark, Tomas Jerlstrom, Fredrik Liedberg, Amir Sherif, Viveka Strock, Henrik Kjolhede

SCANDINAVIAN JOURNAL OF UROLOGY (2022)

添加到收藏夹

Article Urology & Nephrology

Standardized care pathways for patients with suspected urinary bladder cancer: the Swedish experience

Suleiman Abuhasanein, Staffan Jahnson, Firas Aljabery, Truls Gardmark, Tomas Jerlstrom, Fredrik Liedberg, Amir Sherif, Viveka Strock, Henrik Kjolhede

Summary: This study compared the differences in diagnosis and treatment time, tumor characteristics, and management in patients with primary urinary bladder cancer before and after the implementation of a standardized care pathway (SCP) in Sweden. The results showed a decrease in the median time to transurethral resection of bladder tumor (TURBT) after SCP implementation. The proportion of patients discussed at a multidisciplinary team conference (MDTC) increased, but did not reach the recommended levels. Measures should be taken to increase adherence to SCP recommendations and guidelines.

SCANDINAVIAN JOURNAL OF UROLOGY (2022)

添加到收藏夹

Article Biology

Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer

Harriet Rydell, Ylva Huge, Victoria Eriksson, Markus Johansson, Farhood Alamdari, Johan Svensson, Firas Aljabery, Amir Sherif

Summary: This study aims to compare the differences in thromboembolic events (TEE) between peripherally inserted central catheter (PICC) and totally implanted port (PORT) as central venous access during neoadjuvant chemotherapy (NAC) in patients with urothelial muscle-invasive bladder cancer (MIBC). The results show a higher risk of TEE in PICC patients compared to PORT patients, suggesting a preference for the usage of PORTs in MIBC-NAC patients.

LIFE-BASEL (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Number of transurethral procedures after non-muscle-invasive bladder cancer and survival in causes other than bladder cancer

Lars Holmberg, Oskar Hagberg, Christel Haggstrom, Truls Gardmark, Viveka Strock, Firas Aljabery, Staffan Jahnson, Abolfazl Hosseini, Tomas Jerlstrom, Amir Sherif, Karin Soderkvist, Anders Ullen, Mats Enlund, Fredrik Liedberg, Per-Uno Malmstrom

Summary: This study investigated the overall and disease-specific risk of death in patients with non-muscle invasive bladder cancer (NMIBC). The results showed a slightly increased risk of death from non-bladder cancer causes in NMIBC patients, which may be explained by confounding factors. Repeated transurethral procedures during follow-up did not increase the risk of death from non-bladder cancer causes.

PLOS ONE (2022)

添加到收藏夹

Article Andrology

Adverse events during neoadjuvant chemotherapy for muscle invasive bladder cancer-a Swedish retrospective multicentre study of a clinical database

Victoria Eriksson, Jennie Holmlund, Erik Wiberg, Markus Johansson, Ylva Huge, Farhood Alamdari, Johan Svensson, Firas Aljabery, Amir Sherif

Summary: This study aimed to assess the incidence and severity of adverse events (AEs) during neoadjuvant chemotherapy (NAC) for muscle invasive bladder cancer (MIBC), and to investigate the possible effects of AEs on downstaging outcomes. The results showed that NAC in MIBC poses a significant risk for AEs with clinical implications, affecting multiple organ systems. It was also found that patients who prematurely terminated chemotherapy had higher AE grades and decreased downstaging, and that anemia and acute kidney injury were individually associated with decreased downstaging.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2022)

添加到收藏夹

Article Oncology

Immune-Activated B Cells Are Dominant in Prostate Cancer

Aws Saudi, Viqar Banday, A. Ali Zirakzadeh, Martin Selinger, Jon Forsberg, Martin Holmbom, Johan Henriksson, Mauritz Walden, Farhood Alamdari, Firas Aljabery, Ola Winqvist, Amir Sherif

Summary: Contrary to common belief, our study shows that prostate cancer has tumor-associated B-cell responses. We found mature and activated B cells, including effector plasmablasts, in tumor-draining lymph nodes, indicating a B-cell-specific antitumor immune response. This highlights the importance of targeting B cells in prostate cancer immunotherapy.

CANCERS (2023)

添加到收藏夹

Article Cell Biology

Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer

Saskia Kowald, Ylva Huge, Decky Tandiono, Zaheer Ali, Gabriela Vazquez-Rodriguez, Anna Erkstam, Anna Fahlgren, Amir Sherif, Yihai Cao, Lasse D. Jensen

Summary: BCG immunotherapy is an effective adjuvant treatment for non-muscle-invasive bladder cancer. Zebrafish tumor xenograft models were used to study the mechanism and predict the treatment response of BCG. The results show that BCG can reduce tumor size and inhibit cell dissemination, suggesting the potential value of zebrafish models in treatment planning.

CELLS (2023)

添加到收藏夹

Article Health Care Sciences & Services

Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Study of Renal Impairment in Relation to Potential Thromboprophylaxis

Harriet Rydell, Anna Ericson, Victoria Eriksson, Markus Johansson, Johan Svensson, Viqar Banday, Amir Sherif

Summary: In patients with muscle-invasive bladder cancer undergoing neoadjuvant chemotherapy, there is an association between chemotherapy and thromboembolic events, with a significant portion of patients experiencing decreased renal function, making them potentially less suitable for LMWH prophylaxis.

JOURNAL OF PERSONALIZED MEDICINE (2022)

添加到收藏夹

Article Health Care Sciences & Services

A Validation Study of cT-Categories in the Swedish National Urinary Bladder Cancer Register-Norrland University Hospital

Erik Wiberg, Andres Vega, Victoria Eriksson, Viqar Banday, Johan Svensson, Elisabeth Eriksson, Staffan Jahnson, Amir Sherif

Summary: This study aimed to validate the registered clinical tumour categories (cT-categories) in the Swedish National Register for Urinary Bladder Cancer (SNRUBC) for Norrland University Hospital, Sweden, from 2009 to 2020. The study found significant incorrect registration of cT-categories, with a major part of the misclassifications related to tumour-associated hydronephrosis (TAH) and tumour in bladder diverticulum (TIBD). The inclusion of these variables in SNRUBC is recommended to improve correct cT-classification.

JOURNAL OF PERSONALIZED MEDICINE (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.